Lacosamide Oral Solution [Vimpat]
RxNorm 995155
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 995155 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lacosamide Oral Solution [Vimpat].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Lacosamide Oral Solution [Vimpat]
(Atom ID: 3270828)
Patient Education
Lacosamide
Lacosamide is used to control partial onset seizures (seizures that involve only one part of the brain) in adults and children 4 years of age and older. Lacosamide is also used in combination with other medications to control primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 4 years of age and older. Lacosamide is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.